Liang J, Waliany S, Do A, Peterson JL, et al. ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC. Oncologist 2025;30:oyaf217.
PMID: 40674592